Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

Molecular Partners Ag (MOLN) Shares Outstanding (Weighted Average) (2020 - 2023)

Historic Shares Outstanding (Weighted Average) for Molecular Partners Ag (MOLN) over the last 3 years, with Q4 2023 value amounting to $2.13.

  • Molecular Partners Ag's Shares Outstanding (Weighted Average) fell 4345.3% to $2.13 in Q4 2023 from the same period last year, while for Dec 2023 it was $2.13, marking a year-over-year decrease of 4345.3%. This contributed to the annual value of $2.13 for FY2023, which is 4345.3% down from last year.
  • As of Q4 2023, Molecular Partners Ag's Shares Outstanding (Weighted Average) stood at $2.13, which was down 4345.3% from $6.57 recorded in Q3 2023.
  • Over the past 5 years, Molecular Partners Ag's Shares Outstanding (Weighted Average) peaked at $6.57 during Q3 2023, and registered a low of $1.26 during Q4 2020.
  • Over the past 3 years, Molecular Partners Ag's median Shares Outstanding (Weighted Average) value was $5.13 (recorded in 2022), while the average stood at $4.58.
  • Over the last 5 years, Molecular Partners Ag's Shares Outstanding (Weighted Average) had its largest YoY gain of 5207.75% in 2023, and its largest YoY loss of 4345.3% in 2023.
  • Molecular Partners Ag's Shares Outstanding (Weighted Average) (Quarter) stood at $1.26 in 2020, then surged by 198.81% to $3.77 in 2022, then plummeted by 43.45% to $2.13 in 2023.
  • Its Shares Outstanding (Weighted Average) stands at $2.13 for Q4 2023, versus $6.57 for Q3 2023 and $6.45 for Q2 2023.